The evolution of antibiotic resistance in Staphylococcus aureus in Australia

Australian Journal of Medical Science

Volumn 29, Issue 4, 2008, Pages 131-146

  Monaghan, Wayne M ^a  

^a PRINCESS ALEXANDRA HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CEFOXITIN; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; CLAVULANIC ACID; CLINDAMYCIN; COTRIMOXAZOLE; DALFOPRISTIN PLUS QUINUPRISTIN; ERYTHROMYCIN; FUSIDIC ACID; GENTAMICIN; LINCOSAMIDE; LINEZOLID; MACROLIDE; METICILLIN; MIKAMYCIN B; OXACILLIN; OXAZOLIDINONE DERIVATIVE; PANTON VALENTINE LEUKOCIDIN; PENICILLIN G; POLYPEPTIDE ANTIBIOTIC AGENT; PSEUDOMONIC ACID; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; SULBACTAM; TETRACYCLINE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; AUSTRALIA; BACTERIAL CHROMOSOME; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; BACTERIOPHAGE TYPING; BACTERIUM ISOLATE; BACTERIUM ISOLATION; DRUG EFFICACY; DRUG EXPOSURE; DRUG TREATMENT FAILURE; DRUG USE; ENVIRONMENTAL FACTOR; EPSILOMETER TEST; ETHNICITY; GENE CASSETTE; GENETIC VARIABILITY; GEOGRAPHIC DISTRIBUTION; HOSPITAL INFECTION; INFECTION CONTROL; INFECTION PREVENTION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR EVOLUTION; MULTIDRUG RESISTANCE; MULTILOCUS SEQUENCE TYPING; NONHUMAN; PACIFIC ISLANDS; PULSED FIELD GEL ELECTROPHORESIS; REVIEW; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION;

METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS AUREUS;

EID: 58049099716     PISSN: 10381643     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (134)

1. Adhikari RP, Cook GM, Lamont I, Lang S, Heffernan H, Smith JM. 2002. Phenotypic and molecular characterization of community occurring, Western Samoan phage pattern methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother 50:825-831.
2. Aires de Sousa M, Bartzavali C, Spiliopoulou I, Santos Sanches I, Crisostomo MI, de Lencastre, H. 2003. Two international methicillin-resistant Staphylococcus aureus clones endemic in a university hospital in Patras, Greece. J Clin Microbiol 41:2027-2032.
3. Aires de Sousa M, de Lencastre, H. 2003. Evolution of sporadic isolates of methicillin-resistant Staphylococcus aureus (MRSA) in hospitals and their similarities to isolates of community-acquired MRSA. J Clin Microbiol 41:3806-3815.
4. Ayliffe GA. 1997. The progressive intercontinental spread of methicillin-resistant Staphylococcus aureus. Clin Inf Dis 24 Suppl 1:S74-79.
5. Bell JM, and Turnidge JD. 2002. High prevalence of oxacillin-resistant Staphylococcus aureus isolates from hospitalized patients in Asia-Pacific and South Africa: Results from SENTRY Antimicrobial Surveillance Program, 1998-1999. Antimicrob Agents Chemother 46:879-881.
6. Bennett N. 1985. Hospital outbreak of multiresistant Staphylococcus aureus in Victoria, 1979-1984. Med J Aust 142:138-139.
7. Bobin-Dubreux S, Reverdy M, Nervi C, Roughier M, Bolmstrom A, Vandenesch F, Etienne J. 2001. Clinical isolate of vancomycin-heterointermediate Staphylococcus aureus susceptible to methicillin and in vitro selection of a vancomycin-resistant derivative. Antimicrob Agents Chemother 45:349-352.
8. Boyce, JM. 1998. Are the epidemiology and microbiology of methicillin-resistant Staphylococcus aureus changing? JAMA 279:623-624.
9. Boyce JM. 1991. Should we vigorously try to contain and control methicillin-resistant Staphylococcus aureus? Infect Control Hosp Epidemiol 12:46-54.
10. Brady LM, Thomson M, Palmer MA, Harkness JL. 1990. Successful control of endemic MRSA in a cardiothoracic surgical unit. Med J Aust 152:240-245.
11. Brian MJ, Michael A. 1989. Community-acquired infection with methicillin-resistant Staphylococcus aureus in Papua New Guinea. Pediatr Infect Dis J 8:807-808.
12. CDC. 1999. Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus. Morb Mortal Wkly Rep 48:707-710.
13. CDC. 1997. Staphylococcus aureus with reduced susceptibility to vancomycin-United States, 1997. Morb Mortal Wkly Rep 46:765-766.
14. Chambers HE 2001. The changing epidemiology of Staphylococcus aureus? Emerging Infect Dis 7:178-182.
15. Chambers HE 1997. Methicillin resistance in Staphylococci: Molecular and biochemical basis and clinical implications. Clin Microbiol Rev 10:781-791.
16. Chang S, Sievert DM, Hageman JC, Boulton ML, Tenover FC, Downes FP, Sandip Shah PH, Rudrik JT, Pupp GR, Brown WJ, Cardo D, Fridkin SK. 2003. Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene. N Engl J Med 348:1342-7.
17. Charles P, Ward P,, Johnson P, Howden B, Grayson M. 2004a. Bacteraemia caused by heteroresistant vancomycin-intermediate Staphylococcus aureus (hVISA); is it cause for concern? Aust Soc Antimicrob Newsletter 16:1-2.
18. Charles PG, Ward PB, Johnson PDR, Howden BP, Grayson ML. 2004b. Clinical feaures associated with bacteremia due to heterogeneous vancomycin-intermediate Staphylococcus aureus. Clin Inf Dis 38:448-451.
19. Collignon P, Gosbell I, Vickery A, Nimmo G, Stylianopoulos T, Gottlieb T. 1998. Community-acquired methicillin-resistant Staphylococcus aureus in Australia. Lancet 352:145-146.
20. Collins N, Gosbell IB, Wilson SE 2002. Community-acquired MRSA bacteraemia. Med J Aust 177:55-56.
21. Cookson BD. 2000. Methicillin-resistant Staphylococcus aureus in the community: New battlefronts, or are the battles lost? Infect Control Hosp Epidemiol 21:398-403.
22. Coombs G, Christiansen K. 2000. In-vitro detection of Staphylococcus aureus with reduced susceptibility to vancomycin. Aust Soc Antimicrob Newsletter 3:1-4.
23. Coombs, GW, Nimmo GR, Bell JM, Huygens F, O'Brien FG, Malkowski MJ, Pearson JC, Stephens AJ, Giffard P. 2004h. Methicillin-resistant Staphylococcus aureus in the Australian community. Abstracts of the 11th International Symposium on Staphylococci and Staphylococcal Infections. Charleston, South Carolina, USA abstr. CA-05:61.
24. Coombs GW, Nimmo GR, Bell JM, Huygens F, O'Brien FG, Malkowski MJ, Pearson JC, Stephens AJ, Giffard PM. 2004a. Genetic diversity among community methicillin-resistant Staphylococcus aureus strains causing outpatient infections in Australia. J Clin Microbiol 42:4735-4743.
25. Daum RS. 1998. Community-acquired methicillin-resistant Staphylococcus aureus infections. Pediatr Infect Dis J 17:745-746.
26. Drew, RH, Perfect JR, Srinath L, Kurkimilis E, Dowzicky M, Talbot GH. 2000. Treatment of methicillin-resistant Staphylococcus aureus infections with quinupristin-dalfopristin in patients intolerant of or failing prior therapy. J Antimicrob Chemother 46:775-784.
27. Dufour P, Gillet Y, Bes M, Lina G, Vandenesch F, Floret D, Etienne J, Richet H. 2002. Community-acquired methicillin-resistant Staphylococcus aureus infections in France: Emergence of a single done that produces Panton-Valentine Leukocidin. Clin Inf Dis 35:819-824.
28. Enright MC. 2004. Molecular epidemiology of community/nosocomial MRSA. Abstracts of the 11th International Symposium on Staphylococci and Staphylococcal Infections, Charleston, South Carolina, USA:6.
29. Enright MC, Day NPJ, Davies CE, Peacock SJ, Spratt BG. 2000. Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus. J Clin Microbiol 38:1008-1015.
30. Enright MC, Robinson DA, Randle G, Feil EJ, Grundmann H, Spratt BG. 2002. The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA). Proc Natl Acad Sci USA 99:7687-7692.
31. Faoagali JL, Thong ML, Grant D. 1992. Ten years' experience with methicillin-resistant Staphylococcus aureus in a large Australian hospital. J Hosp Infect 20:113-119.
32. Fell EJ, Cooper JE, Grundmann H, Robinson DA, Enright MC, Berendt T, Peacock SJ, Smith JM, Murphy M, Spratt BG, Moore CE, Day NPJ. 2003. How clonal is Staphylococcus aureus? J Bacteriol 185:3307-3316.
33. Flint JA, Ryan P, Gordon DL. 1998. Prevalence of MRSA in South Australian nursing homes. Med J Aust 169:559-560.
34. Fridkin SK. 2001. Vancomycin-intermediate and -resistant Staphylococcus aureus: What the Infectious Disease specialist needs to know. Clin Inf Dis 32:108-115.
35. Gedney J, Lacey RW. 1982. Properties of methicillin-resistant staphylococci now endemic in Australia. Med J Aust 1:448-450.
36. Gillet Y, Issartel B, Vanhems P, Fournet JC, Lina G, Bes M, Vandenesch F, Piemont Y, Brousse N, Etienne FD, Etienne J. 2002. Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotizing pneumonia in young immunocompetent patients. Lancet 359:753-759.
37. Givney R, Vickery A, Holliday A, Pegler M, Benn R. 1998. Evolution of an endemic methicillin-resistant Staphylococcus aureus population in an Australian hospital from 1967 to 1996. J Clin Microbiol 36:552-556.
38. Gold J. 1982. Putting MRSA into perspective. Med J Aust 2:453-454.
39. Gosbell IB, Mercer JL, Neville SA, Chant KG, Munro R. 2001a. Community-acquired, non-multiresistant oxacillin-resistant Staphylococcus aureus (NORSA) in South Western Sydney. Pathol 33:206-210.
40. Gosbell IB, Mercer JL, Neville SA, Crone SA, Chant KG, Jalaludin BB, Munro R. 2001b. Non-multiresistant and multiresistant methicillin-resistant Staphylococcus aureus in community-acquired infections. Med J Aust 174:627-630.
41. Gosbell IB, Mitchell DH, Ziochos H, Ward PB. 2003. Emergence of hetero-vancomycin-intermediate Staphylococcus aureus (hVISA) in Sydney. Med J Aust 178:354.
42. Gottlieb T, Mitchell D. 1998. The independent evolution of resistance to ciprofloxacin, rifampicin, and fusidic acid in methicillin-resistant Staphylococcus aureus in Australian teaching hospitals (1990-1995). J Antimicrob Chemother 42:67-73.
43. Hanaki H, Kuwahara-Arai K, Boyle-Vavra S, Daum RS, Labischinski H, Hiramatsu K. 1998. Activated cell-wall synthesis is associated with vancomycin resistance in methicillin-resistant Staphylococcus aureus clinical strains Mu3 and Mu50. J Antimicrob Chemother 42:199-209.
44. Hiramatsu K. 2001. Vancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistance. Lancet Inf Dis 1:147-155.
45. Hiramatsu K. 1998. The emergence of Staphylococcus aureus with reduced susceptibililty to vancomycin in Japan. Am J Med 104:7S-10S.
46. Hiramatsu K, Aritaka N, Hanaki H, Kawasaki S, Hosoda Y, Hori S, Fukuchi Y, Kobayashi I. 1997a. Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin. Lancet 350:1670-1673.
47. Hiramatsu K, Cui L, Kuroda M, Ito T. 2001. The emergence and evolution of methicillin-resistant Staphylococcus aureus. Trends in Microbiology 9:486-493.
48. Hiramatsu K, Hanaki H, Ino T, Yabuta K, Oguri T, Tenover FC. 1997b. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J Antimicrob Chemother 40:135-136.
49. Hiramatsu K, Okuma K, Ma XX, Yamamoto M, Hori S, Kapi M. 2002. New trends in Staphylococcus aureus infections: glycopeptide resistance in hospital and methicillin resistance in the community, Curr Opin Infect Dis 15:407-413.
50. Hiramatsu K, Watanabe S, Takeuchi F, Ito T, Baba T. 2004. Genetic characterization of methicillin-resistant Staphylococcus aureus. Vaccine 22:S5-S8.
51. Howe RA, Wootton M, Walsh TR, Bennett PM, and MacGowan AP. 1999. Expression and detection of hetero-vancomycin resistance in Staphylococcus aureus. J Antimicrob Chemother 44:675-678.
52. Howe RA, Monk A, Wootton M, Walsh TR, Enright MC. 2004. Vancomycin susceptibility within methicillin-resistant Staphylococcus aureus lineages. Emerg Infect Dis 10:855-857.
53. Howe RA, Wootton M, Walsh TR, Bennett PM, MacGowan AP. 2000. Heterogeneous resistance to vancomycin in Staphylococcus aureus. J Antimicrob Chemother 45:130-131.
54. Huygens F, Stephens AJ, Nimmo GR, Giffard PM. 2004. mecA locus diversity in methicillin-resistant Staphylococcus aureus isolates in Brisbane, Australia, and the development of a novel diagnostic procedure for the Western Samoan phage pattern clone. J Clin Microbiol 42:1947-1955.
55. Inglis B, El-Adhami W, Stewart PR. 1993. Methicillin-sensitive and -resistant homologues of Staphylococcus aureus occur together among clinical isolates. J Infect Dis 167:323-328.
56. Ito T, Katayama Y, Asada K, Mori N, Tsutsumimoto K, Tiensasitorn C, Hiramatsu K. 2001. Structural comparison of three types of Staphylococcal cassette chromosome mec integrated in the chromosome in methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 45:1323-1336.
57. Ito T, Ma XX, Takeuchi F, Okuma K, Yuzawa H, Hiramatsu K. 2004. Novel type V Staphylococcal cassette chromosome mec driven by a novel cassette chromosome recombinase, ccrC. Antimicrob Agents Chemother 48:2637-2651.
58. Jevons MP. 1961. "Celbenin" -resistant Staphylocci. Br Med J 1:124-125.
59. Jones ME, Mayfield DC, Thornsberry C, Karlowsky JA, Sahm DF, Peterson D. 2002. Prevalence of oxacillin resistance in Staphylococcus aureus among inpatients and outpatients in the United States during 2000. Antimicrob Agents Chemother 46:3104-3105.
60. Katayama Y, Ito T, Hiramatsu K. 2000. A new class of genetic element, Staphylococcus cassette chromosome mec, encodes methicillin resistance in Staphylococcus aureus. Antimicrob Agents Chemother 44:1549-1555.
61. King K, Brady L, Thomson M, Harkness JL. 1982. Antibiotic-resistant staphylococci in a teaching hospital. Med J Aust 2:461-465.
62. King K, Harvey K. 1985. MRSA revisited. Med J Aust 142:88-89.
63. Kuroda M et al. 2001. Whole genome sequencing of meticillin-resistant Staphylococcus aureus. Lancet 357:1225-1240.
64. Kuwahara-Arai K, Kondo N, Hori S, Tateda-Suzuki E, Hiramatsu K. 1996. Suppression of methicillin resistance in a mecA-containing pre-methicillin-resistant Staphylococcus aureus strain is caused by the mecI-mediated repression of PBP 2′ production. Antimicrob Agents Chemother 40:2680-2685.
65. Liassine N, Auckenthaler R, Descombes M, Bes M, Vandenesch F, Etienne J. 2004. Community-acquired methicillin-resistant Staphylococcus aureus isolated in Switzerland contains the Panton-Valentine Leukocidin or exfoliative toxin genes. J Clin Microbiol 42:825-828.
66. Lim TT, Chong FN, O'Brien FG, Grubb WB. 2003. Are all community methicillin-resistant Staphylococcus aureus related? A comparison of their mec regions. Pathol 35:336-343.
67. Lim TT, Coombs GW, and Grubb WB. 2002. Genetic organization of mecA and mecA-regulatory genes in epidemic methicillin-resistant Staphylocccus aureus from Australia and England. J Antimicrob Chemother 50:819-824.
68. Lina G, Piemont Y, Godail-Gamot F, Bes M, Peter M, Gauduchon V, Vandenesch F, Etienne J. 1999. Involvement of Panton-Valentine Leukocidin-Producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Inf Dis 29:1128-1132.
69. Liu C, Chambers HE 2003. Staphylococcus aureus with heterogeneous resistance to vancomycin: epidemiology, clinical significance, and critical assessment of diagnostic methods. Antimicrob Agents Chemother 47:3040-3045.
70. Ma XX, Ito T, Tiensasitorn C, Jamklang M, Chongtrakool P, Boyle-Vavra S, Daum RS, Hiramatsu K. 2002. Novel type of Staphylococcal casette chromosome mec identified in community-acquired methicillin-resistant Staphylococcus aureus strains. Antimicrob Agents Chemother 46:1147-1152.
71. Maguire GP, Arthur AD, Boustead PJ, Dwyer B, Currie BJ. 1998. Clinical experience and outcomes of community-acquired and nosocomial methicillin-resistant Staphylococcus aureus in a northern Australian hospital. J Hosp Inf 38:273-281.
72. Maguire GP, Arthur AD, Boustead PJ, Dwyer B, Currie BJ. 1996. Emerging epidemic of community-acquired methicillin-resistant Staphylococcus aureus infection in the Northern Territory. Med J Aust 164:721-723.
73. Marples RR. 1989. Antibiotic resistance in Staphylococcus aureus. Med J Aust 150:58-59.
74. McDonald PJ. 1982. Methicillin-resistant staphylococci: A sign of the times? Med J Aust 1:445-446.
75. Merlino J, Watson J, Rose B, Beard-Pegler M, Gottlieb T, Bradbury R, Harbour C. 2002. Detection and expression of methicillin/oxacillin resistance in multidrug-resistant and non-multidrug-resistant Staphylococcus aureus in Central Sydney, Australia. J Antimicrob Chemother 49:793-801.
76. Mitchell J, MacCulloch D, Morris A. 1996. MRSA in the community. NZ Med J 109:411.
77. Moore PCL, Lindsay JA. 2002. Molecular characterisation of the dominant UK methicillin-resistant Staphylococcus aureus strains, EMRSA-15 and EMRSA-16. J Med Microbiol 51:516-521.
78. Moreno FCC, Jorgensen JH, Patterson JE. 1995. Methicillin-resistant Staphylococcus aureus as a community organism. Clin Inf Dis 21:1308-1312.
79. Munckhof WJ, Harper J, Schooneveldt J, Nimmo GR. 2002. Recent appearance of clindamycin resistance in community-acquired methicillin-resistant Staphylococcus aureus (MRSA) in south-east Queensland. Med J Aust 176:243-244.
80. Munckhof WJ, Schooneveldt J, Coombs GW, Hoare J, Nimmo GR. 2003. Emergence of community-acquired methicillin-resistant Staphylococcus aureus (MRSA) infection in Queensland, Australia. Int J Infect Dis 7:259-267.
81. Neu HC. 1990. The use of mupirocin in controlling methicillin-resistant Staphylococcus aureus [editorial]. Infect Control Hosp Epidemiol 11:11-12.
82. Nimmo G, Bell J, Mitchell D, Gosbell I, Pearman J, Turnidge J. 2003. Antimicrobial Resistance in Staphylococcus aureus in Australian Teaching Hospitals, 1989-1999. Microb Drug Res 9:155-160.
83. Nimmo G, Playford E. 2003. Community-acquired MRSA bacteraemia: four additional cases including one associated with severe pneumonia. Med J Aust 178:245.
84. Nimmo GR, Looke DFM. 2001. Non-multiresistant methicillin-resistant Staphylococcus aureus in the community. Med J Aust 174:617-618.
85. Nimmo GR, Schooneveldt J, O'Kane G, McCall B, Vickery A. 2000. Community Acquisition of Gentamicin-Sensitive Methicillin-Resistant Staphylococcus aureus in Southeast Queensland, Australia. J Clin Microbiol 38:3926-3931.
86. O'Brien FG, Coombs GW, Christiansen K, Grubb WB. 2004. Distribution of the staphylococcal cassette chromosome mec type V in community methicillin-resistant Staphylococcus aureus isolated in Australia. Abstracts of the 11th International Symposium on Staphylococci and Staphylococcal Infections, Charleston, South Carolina, USA MG-07:165.
87. O'Brien FG, Lim TT, Chong FN, Coombs GW, Enright MC, Robinson DA, Monk A, Said-Salim B, Kreiswirth BN, Grubb WB. 2004. Diversity among community isolates of methicillin-resistant Staphylococcus aureus in Australia. J Clin Microbiol 42:3185-3190.
88. O'Brien FG, Pearman JW, Gracey M, Riley TV, Grubb WB. 1999. Community Strain of Methicillin-resistant Staphylococcus aureus Involved in a Hospital Outbreak. J Clin Microbiol 37:2858-2862.
89. O'Kane GM, Gottlieb T, Bradbury R. 1998. Staphylococcal bacteraemia: the hospital or the home? A review of Staphylococcus aureus bacteraemia at Concord Hospital in 1993. Aust NZ J Med 28:23-27.
90. Okuma K, Iwakawa K, Turnidge JD, Grubb WB, Bell JM, O'Brien FG, Coombs GW, Pearman JW, Tenovet FC, Kapi M, Tiensasitorn C, Ito T, Hiramatsu K. 2002. Dissemination of new methicillin-resistant Staphylococcus aureus clones in the communitiy. J Clin Microbiol 40:4289-4294.
91. Oliveira DC, Tomasz A, de Lencastre H. 2001. The evolution of pandemic clones of methicillin-resistant Staphylococcus aureus: identification of two ancestral genetic backgrounds and the associated mec elements. Microb Drug Res 7:349-361.
92. Palmer B, Dula R, Zakaria W, Reagan D. 1994. Factors associated with outpatient acquisition of methicillin-resistant Staphylococcus aureus (MRSA). Infect Control Hosp Epidemiol 15:S22.
93. Panagea S, Perry JD, Gould FK. 1999. Should clindamycin be used as treatment of patients with infections caused by erythromycin-resistant staphylococci? J Antimicrob Chemother 44:581-582.
94. Pavillard, R, Harvey K, Douglas D, Hewstone A, Andrew J, Collopy B, Asche V, Carson P, Davidson A, Gilbert G, Spicer J, and Tosolini F. 1982. Epidemic of hospital-acquired infection due to methicillin-resistant Staphylococcus aureus in major Victorian hospitals. Med J Aust 1:451-454.
95. Peacock SJ, de Silva GDI, Justice A, Cowland A, Moore CE, Winearls CG, Day NPJ. 2002. Comparison of multilocus sequence typing and pulsed-field gel electrophoresis as tools for typing Staphylococcus aureus isolates in a microepidemiological setting. J Clin Microbiol 40:3764-3770.
96. Pearman J, Coombs G, Grubb W, O'Brien F. 2001. A British epidemic strain of methicillin-resistant Staphylococcus aureus (UK EMRSA-15) in Western Australia. Med J Aust 174:662.
97. Pearman, JW, Christiansen KJ, Annear DI, Goodwin CS, Metcalf C, Donovan FP, Macey KL, Bassette LD, Powell IM, Green JM, Harper WE, McKelvie MS. 1985. Control of methicillin-resistant Staphylococcus aureus (MRSA) in an Australian metropolitan teaching hospital complex. Med J Aust 142:103-108.
98. Peleg A, Munckhof WJ, Kleinschmidt SL, Stephens A, Huygens F. 2004. Life threatening community-onset methicillin-resistant Staphylococcus aureus infection; an emerging and highly virulent pathogen in southeast Queensland, Australia. Abstracts of the 11th International Symposium on Staphylococci and Staphylococcal Infections. Charleston, South Carolina, USA CA-16:72.
99. Reagan DR, Doebbeling BN, Pfaller MA et al. 1991. Elimination of coincident Staphylococcus aureus nasal and hand carriage with intranasal application of mupirocin calcium ointment. Ann Intern Med 114:101-106.
100. Riley D, MacCulloch D, Morris A. 1998. Methicillin-resistant S. aureus in the suburbs. NZ Med J 111:59.
101. Riley TV, Carson CF, Bowman RA, Mulgrave L, Golledge CL, Pearman JW, Grubb WB. 1994. Mupirocin-resistant methicillin-resistant Staphylococcus aureus in Western Australia. Med J Aust 161:397-398.
102. Riley TV, Pearman JW, Rouse IL. 1995. Changing epidemiology of methicillin-resistant Staphylococcus aureus in Western Australia. Med J Aust 163:412-414.
103. Riley TV, Rouse IL. 1995. Methicillin-resistant Staphylococcus aureus in Western Australia, 1983-1992. J Hosp Inf 29:177-188.
104. Riley TV, Rouse IL. 1994. Methicillin-resistant Staphylococcus aureus in Western Australia, 1983 to 1992. Commun Dis Intell 18:226-229.
105. Robinson DA, Enright MC. 2004b. Multilocus sequence typing and the evolution of methicillin-resistant Staphylococcus aureus. Clin Microbiol Infect 10:92-97.
106. Robinson DA, Enright MC. 2004a. Evolution of Staphylococcus aureus by large chromosomal replacements. J Bacteriol 186:1060-1064.
107. Robinson DA, Enright MC. 2003. Evolutionary models of the emergence of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 47:3926-3934.
108. Rountree P, Beard M. 1968. Hospital strains of Staphylococcus aureus, with particular reference to methicillin-resistant strains. Med J Aust 26:1163-1168.
109. Salmenlinna S, Lyytikainen O, Vuopio-Varkila J. 2002. Community-acquired methicillin-resistant Staphylococcus aureus, Finland. Emerging Infect Dis 8:602-607.
110. Smith TL, Pearson ML, Wilcox KR, Cosme Cruz PH, Lancaster MV, Robinson-Dunn B, Tenover FC, Zervos MJ, Band JD, White E, Jarvis WR. 1999. Emergence of vancomycin resistance in Staphylococcus aureus. N Engl J Med 340:493-501.
111. Song J, Hiramatsu K, Suh JY, Ko KS, Ito T, Kapi M, Kiem S, Kim Y, Oh WS, Peck KR, Lee NY. 2004. Emergence in Asian countries of Staphylococcus aureus with reduced susceptibility to vancomycin. Antimicrob Agents Chemother 48:4926-4928.
112. Tenover F, Biddle J, Lancaster M. 2001. Increasing resistance to vancomycin and other glycopeptides in Staphylococcus aureus. Emerging Infectious Diseases 7:327-332.
113. Torvaldsen S, Roberts C, Riley TV. 1999. The continuing evolution of methicillin-resistant Staphylococcus aureus in Western Australia. Infect Control Hosp Epidemiol 20:133-135.
114. Townsend DE, Ashdown N, Bolton S, Bradley J, Duckworth G, Moorhouse EC, Grubb WB. 1987. The international spread of methicillin-resistant Staphylococcus aureus. J Hosp Inf 9:60-71.
115. Townsend, D. E., Ashdown N, Bradley JM, Pearman JW, Grubb WB. 1984. "Australian" methicillin-resistant Staphylococcus aureus in a London hospital? Med J Aust 141:339-340.
116. Townsend DE, Ashdown N, Pearman JW, Annear DI, Grubb WB. 1985. Genetics and epidemiology of methicillin-resistant Staphylococcus aureus isolated in a Western Australian Hospital. Med J Aust 142:108-111.
117. Tsiodras S, Gold HS, Sakoulas G, Eliopoulos GM, Wennersten C, Moellering RC Jr, Venkataraman L, Ferraro MJ. 2001. Linezolid resistance in a clinical isolate of Staphylococcus aureus. Lancet 358:207-208.
118. Turnidge J. 1990. MRSA - is control worthwhile and feasible? Med J Aust 152:225-226.
119. Turnidge J, Lawson P, Munro R, Benn R. 1989. A national survey of antimicrobial resistance in Staphylococcus aureus in Australian teaching hospitals. Med J Aust 150:65-72.
120. Turnidge JD, Bell JM. 2000. Methicillin-resistant Staphylococcus aureus evolution in Australia over 35 years. Microb Drug Res 6:223-229.
121. Turnidge JD, Nimmo GR, Francis G. 1996. Evolution of resistance in Staphylococcus aureus in Australian teaching hospitals. Med J Aust 164:68-71.
122. Udo EE, Pearman JW, Grubb WB. 1994. Emergence of high-level mupirocin resistance in methicillin-resistant Staphylococcus aureus in Western Australia, J Hosp Inf 26:157-165.
123. Udo EE, Pearman JW,, Grubb WB. 1993. Genetic analysis of community isolates of methicillin-resistant Staphylococcus aureus in Western Australia. J Hosp Inf 25:97-108.
124. Vandenesch F, Naimi T, Enright MC, Lina G, Nimmo GR, Heffernan H, Liassine N, Bes M, Greenland T, Reverdy M, Etienne J. 2003. Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine Leukocidin genes: Worldwide emergence. Emerging Infect Dis 9:978-984.
125. Vickery AM. 1993. Strains of methicillin-resistant Staphylococcus aureus isolated in Australian hospitals from 1986 to 1990. J Hosp Inf 24:139-151.
126. Vickery, AM, Beard-Pegler MA, Stubbs E. 1986. Phage typing patterns and lysogenicity of methicillin-resistant Staphylococcus aureus from Sydney, Australia. J Med Microbiol 22:209-216.
127. Voss A, Doebbeling BN. 1995. The worldwide prevalence of methicillin-resistant Staphylococcus aureus. Inter J Antimicrob Agents 5:101-106.
128. Walsh TR, Bolmstrom A, Qwarnstrom A, Phion H, Wootton M, Howe RA, MacGowan AP, Diekema D. 2001a. Evaluation of current methods for detection of staphylococci with reduced susceptibility to glycopeptides. J Clin Microbiol 39:2439-2444.
129. Walsh TR, Howe RA, Wootton M, Bennett PM, MacGowan AP. 2001b. Detection of glycopeptide resistance in Staphylococcus aureus. J Antimicrob Chemother 47:357-358.
130. Ward PB, Johnson PDR, Grabsch EA, Mayall BC, Grayson ML. 2001. Treatment failure due to methicillin-resistant Staphylococcus aureus (MRSA) with reduced susceptibility to vancomycin. Med J Aust 175:480-483.
131. Warshawsky B, Hussain Z, Gregson DB, Alder R, Austin M, Bruckschwaiger D, Chagla AH, Daley J, Duhaime C, McGhie K, Pollett G, Potters H, Schiedel L. 2000. Hospital and community-based surveillance of methicillin-resistant Staphylococcus aureus: Previous hospitalization is the major risk factor. Infect Control Hosp Epidemiol 21:72 4-727.
132. Watson J, Givney R, Beard-Pegler M, Rose B, Merlino J, Vickery A, Gottlieb T, Bradbury R, Harbour C. 2003. Comparative Analysis of Multidrug-Resistant, Non-Multidrug-Resistant, and Archaic Methicillin-Resistant Staphylococcus aureus Isolates from Central Sydney, Australia. J Clin Microbiol 41:867-872.
133. Whitby M, McLaws M, Berry G. 2001. Risk of death from methicillin-resistant Staphylococcus aureus bacteraemia: a meta-analysis. Med J Aust 175:264-267.
134. Wootton M, Howe RA, Hillman R, Walsh TR, Bennett PM, MacGowan AP. 2001. A modified population analysis profile (PAP) method to detect hetero-resistance to vancomycin in Staphylococcus aureus in a UK hospital. J Antimicrob Chemother 399-403.